Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$37.41 - $62.25 $2.18 Million - $3.63 Million
-58,256 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$35.69 - $52.72 $192,583 - $284,477
-5,396 Reduced 8.48%
58,256 $2.53 Million
Q4 2020

Feb 02, 2021

BUY
$31.71 - $57.97 $1.19 Million - $2.17 Million
37,449 Added 142.92%
63,652 $3.31 Million
Q3 2020

Nov 05, 2020

BUY
$27.03 - $47.97 $90,388 - $160,411
3,344 Added 14.63%
26,203 $857,000
Q2 2020

Aug 12, 2020

BUY
$23.2 - $54.8 $530,328 - $1.25 Million
22,859 New
22,859 $1.1 Million

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $171M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.